Michael J. Morris, MD

Medical Oncologist

Clinical Director, Genitourinary Medical Oncology Service & Prostate Cancer Section Head, Division of Solid Tumor Oncology

Conditions Treated

Michael J. Morris, MD
LocationA pin, used as a metaphor for the concept of location. Locations Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.
Phone iconAn icon showing a telephone. New Patient Appointments Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.
Phone iconAn icon showing a telephone. Phone Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.
Twitter isolated iconAn icon representing the Twitter social media site, but isolated from it's normal branded background. Follow Me Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

About Me

I am a board-certified medical oncologist who specializes in treating men with prostate cancer, particularly those who have metastatic disease (disease that has spread to distant organs) or who are at high risk of developing metastatic disease. I am the Prostate Cancer Section Head, which means I lead a group of experts who are dedicated to researching and treating this disease.

Much of my research focuses on drugs that can deliver radioactive molecules targeted specifically to prostate cancer cells or to the distant areas where the cancer spreads. These drugs can be used alone or in combination with other anti-cancer strategies. This research represents a team effort between medical oncologists, nuclear medicine doctors, and radiologists to bring these novel and exciting drugs to the people with prostate cancer who need them.

I am also interested in developing new ways to image prostate cancer using unique, prostate-cancer-specific PET scans and other new imaging methods. This type of imaging not only provides insight into where the prostate cancer is located but informs us about its biology as well. Treatments can then be more precisely and personally tailored to an individual’s disease.

One of my priorities is increasing patient access to clinical trials. I am one of the leaders of the Prostate Cancer Clinical Trials Consortium. This initiative is designed to increase patient access to clinical trials across the country. I also chair the Genitourinary Committee of the National Cancer Institute’s cooperative group Alliance for Clinical Trials in Oncology, which facilitates testing new drugs nationwide. I have been very involved with the American Society of Clinical Oncology, taking various roles centering around prostate cancer and other genitourinary diseases.

  • Clinical Expertise: Prostate Cancer; New Investigational Agents
  • Awards and Honors: Castle Connolly: New York Magazine Top Doctors (2013; 2015-2018)
  • Languages Spoken: English
  • Education: MD, Mount Sinai School of Medicine
  • Residencies: Medicine - Columbia Presbyterian Medical Center
  • Fellowships: Oncology/Hematology - Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College
  • Board Certifications: Medical Oncology

See My Colleagues

Publications

Visit PubMed for a full listing of Michael J. Morris’ journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Insurance

Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicare and New York State Medicaid also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.